Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [5419]
News [12581]
Articles [170]
Editorials [5]
Conferences [246]
elearning [17]
Enzalutamide preferable to bicalutamide plus LHRH analogue in prostate cancer
Dr Simon Chowdhury - Guy's Hospital, London, UK
Enzalutamide preferable to bicalutamide plus LHRH analogue in prostate cancer ( Dr Simon Chowdhury - Guy's Hospital, London, UK )
9 Jun 2015
Screening to identify unsuitable candidates for ipilimumab in advanced melanoma
Dr Pier Francesco Ferrucci - European Institute of Oncology, Milan, Italy
Screening to identify unsuitable candidates for ipilimumab in advanced melanoma ( Dr Pier Francesco Ferrucci - European Institute of Oncology, Milan, Italy )
9 Jun 2015
Nivolumab alone superior to ipilimumab alone in advanced melanoma
Dr Pier Francesco Ferrucci - European Institute of Oncology, Milan, Italy
Nivolumab alone superior to ipilimumab alone in advanced melanoma ( Dr Pier Francesco Ferrucci - European Institute of Oncology, Milan, Italy )
8 Jun 2015
Extended adjuvant therapy for HER2-positive early breast cancer
Prof Arlene Chan - The Mount Hospital, Perth, Australia
Extended adjuvant therapy for HER2-positive early breast cancer ( Prof Arlene Chan - The Mount Hospital, Perth, Australia )
8 Jun 2015
New dexamethasone combination yields two-fold improvement in median PFS in...
Prof Meletios Dimopoulos - University of Athens, Athens, Greece
New dexamethasone combination yields two-fold improvement in median PFS in multiple myeloma ( Prof Meletios Dimopoulos - University of Athens, Athens, Greece )
5 Jun 2015
Survival benefits following eribulin in advanced liposarcoma and leiomyosarcoma
Dr Patrick Schöffski - University Hospitals Leuven, Leuven, Belgium
Survival benefits following eribulin in advanced liposarcoma and leiomyosarcoma ( Dr Patrick Schöffski - University Hospitals Leuven, Leuven, Belgium )
5 Jun 2015
ASCO 2015: Latest developments in multiple myeloma
Prof Philippe Moreau, Prof Sagar Lonial, Prof Meletios Dimopoulos
ASCO 2015: Latest developments in multiple myeloma ( Prof Philippe Moreau, Prof Sagar Lonial, Prof Meletios Dimopoulos )
1 Jun 2015
Adjuvant denosumab may preserve bone health in postmenopausal breast cancer...
Prof Michael Gnant - Medical University of Vienna, Vienna, Austria
Adjuvant denosumab may preserve bone health in postmenopausal breast cancer patients: results of the ABCSG-18 trial ( Prof Michael Gnant - Medical University of Vienna, Vienna, Austria )
1 Jun 2015
ASCO 2015: Latest in chronic lymphocytic leukaemia
Prof Stephan Stilgenbauer and Dr Jacqueline Barrientos
ASCO 2015: Latest in chronic lymphocytic leukaemia ( Prof Stephan Stilgenbauer and Dr Jacqueline Barrientos )
1 Jun 2015
Cobimetinib plus vemurafenib for advanced BRAF-mutated melanoma
Dr James Larkin - Royal Marsden Hospital, London, UK
Cobimetinib plus vemurafenib for advanced BRAF-mutated melanoma ( Dr James Larkin - Royal Marsden Hospital, London, UK )
1 Jun 2015
Dasatinib plus intensive chemo versus stem cell transplant for Philadelphia...
Dr William Slayton - University of Florida, Gainsville, USA
Dasatinib plus intensive chemo versus stem cell transplant for Philadelphia chromosome positive ALL ( Dr William Slayton - University of Florida, Gainsville, USA )
1 Jun 2015
ASCO 2015: Latest developments in prostate cancer treatment
Prof Cora Sternberg, Prof Noel Clarke, Prof Eleni Efstathiou, Prof Karim Fizazi
ASCO 2015: Latest developments in prostate cancer treatment ( Prof Cora Sternberg, Prof Noel Clarke, Prof Eleni Efstathiou, Prof Karim Fizazi )
31 May 2015

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation